• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本的新生儿筛查。

Newborn screening in Japan.

作者信息

Aoki Kikumaro

机构信息

Kagawa Nutrition University, Saitama, Japan.

出版信息

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:80.

PMID:15906702
Abstract

In the 1970's, the government began to take steps for the treatment of congenital diseases. Mass newborn screening was started in October 1977 throughout Japan in order to detect five inborn errors of metabolism including phenylketonuria, maple syrup urine disease, homocystinuria, histidinemia, and galactosemia. In 1979, mass screening for congenital hypothyroidism was added to the original program. In 1989, screening for congenital adrenal hyperplasia was added and in 1992, screening of histidinemia was discontinued. Currently, screening covers six diseases. The government paid half the cost of screening tests initially and in 2001 this was raised to the full cost (approximately 3000 yen). Parents pay for sample collection. The program is carried out according to law. A new activity involving screening for Wilson disease now necessitates taking dried blood specimens from children 1-3 years old.

摘要

20世纪70年代,政府开始采取措施治疗先天性疾病。1977年10月,日本全国开始进行大规模新生儿筛查,以检测包括苯丙酮尿症、枫糖尿症、同型胱氨酸尿症、组氨酸血症和半乳糖血症在内的五种先天性代谢缺陷。1979年,先天性甲状腺功能减退症的大规模筛查被纳入原项目。1989年,增加了先天性肾上腺皮质增生症的筛查,1992年,组氨酸血症的筛查被停止。目前,筛查涵盖六种疾病。政府最初支付筛查测试费用的一半,2001年提高到全额费用(约3000日元)。家长支付样本采集费用。该项目依法实施。一项涉及威尔逊病筛查的新活动现在需要采集1至3岁儿童的干血标本。

相似文献

1
Newborn screening in Japan.日本的新生儿筛查。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:80.
2
Long term follow-up of patients with inborn errors of metabolism detected by the newborn screening program in Japan.日本新生儿筛查项目检测出的先天性代谢缺陷患者的长期随访
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:19-23.
3
Neonatal screening and monitoring system in Taiwan.台湾的新生儿筛查与监测系统。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:91-3.
4
Newborn screening in the Philippines.菲律宾的新生儿筛查。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:87-8.
5
[25 years Austrian screening program for inborn errors of metabolism at the Vienna University].[维也纳大学开展的为期25年的奥地利先天性代谢缺陷筛查项目]
Wien Klin Wochenschr. 1992;104(16):510-3.
6
Comprehensive cost-utility analysis of newborn screening strategies.新生儿筛查策略的综合成本效用分析
Pediatrics. 2006 May;117(5 Pt 2):S287-95. doi: 10.1542/peds.2005-2633H.
7
Newborn screening: an overview.新生儿筛查:概述
Clin Lab Sci. 2002 Fall;15(4):229-38.
8
[Evaluation of the usefulness for neonatal mass screening in light of 35 years personal experience].[基于35年个人经验对新生儿群体筛查效用的评估]
Med Wieku Rozwoj. 1999 Oct-Dec;3(4):529-59.
9
Newborn screening for inborn errors of metabolism in Japan. A history of the development of newborn screening.日本新生儿代谢性遗传病筛查。新生儿筛查的发展历程。
Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:8-25.
10
[Progress in the early detection of inborn errors of metabolism].[先天性代谢缺陷早期检测的进展]
Probl Med Wieku Rozwoj. 1981;10:69-85.

引用本文的文献

1
Long-Term Outcomes of Adult Patients with Homocystinuria before and after Newborn Screening.新生儿筛查前后成年同型胱氨酸尿症患者的长期结局
Int J Neonatal Screen. 2020 Jul 30;6(3):60. doi: 10.3390/ijns6030060.
2
Screening for galactosemia: is there a place for it?半乳糖血症筛查:有必要进行吗?
Int J Gen Med. 2019 May 23;12:193-205. doi: 10.2147/IJGM.S180706. eCollection 2019.
3
High-Quality Exome Sequencing of Whole-Genome Amplified Neonatal Dried Blood Spot DNA.全基因组扩增新生儿干血斑DNA的高质量外显子组测序
PLoS One. 2016 Apr 18;11(4):e0153253. doi: 10.1371/journal.pone.0153253. eCollection 2016.
4
Newborn screening for homocystinuria.同型胱氨酸尿症的新生儿筛查。
Cochrane Database Syst Rev. 2015 Oct 1;2015(10):CD008840. doi: 10.1002/14651858.CD008840.pub4.
5
Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.中国苯丙酮尿症新生儿筛查与治疗的现状及前景——与美国、英国和日本的现状比较
Intractable Rare Dis Res. 2013 Nov;2(4):106-14. doi: 10.5582/irdr.2013.v2.4.106.
6
Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue.从早产儿中分离用于遗传分析的人类基因组 DNA:新生儿干血斑、全血和脐带组织的比较。
BMC Genet. 2013 Oct 29;14:105. doi: 10.1186/1471-2156-14-105.
7
Robustness of genome-wide scanning using archived dried blood spot samples as a DNA source.利用存档的干血斑样本作为 DNA 来源进行全基因组扫描的稳健性。
BMC Genet. 2011 Jul 4;12:58. doi: 10.1186/1471-2156-12-58.
8
Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis.储存的干血斑中的全基因组扩增 DNA 可用于高分辨率熔解曲线和测序分析,结果可靠。
BMC Med Genet. 2011 Feb 9;12:22. doi: 10.1186/1471-2350-12-22.
9
Genome-wide scans using archived neonatal dried blood spot samples.使用存档的新生儿干血斑样本进行全基因组扫描。
BMC Genomics. 2009 Jul 4;10:297. doi: 10.1186/1471-2164-10-297.
10
Newborn screening in the Asia Pacific region.亚太地区的新生儿筛查。
J Inherit Metab Dis. 2007 Aug;30(4):490-506. doi: 10.1007/s10545-007-0687-7. Epub 2007 Jul 23.